Philippe Tramoy

Philippe Tramoy is a seasoned partner at Seventure Partners since November 2013, where involvement centers around the Quadrivium Fund, which finances start-ups in Digital technologies and Life sciences linked to prominent academic institutions. Additionally, Tramoy holds board member positions at several biotechnology firms, including CryoCapCell, PEP-Therapy, and Aenitis Technologies, focusing on innovative solutions in electron microscopy, targeted cancer therapies, and fluid component separation. Past board memberships also include roles at Scipio Bioscience, myBrain Technologies, Keen Eye Technologies, MilliDrop, DIABNEXT, and horseCom. Educational credentials include multiple Master's degrees in Marketing, Finance, Immunology & Molecular Biology, and Biochemistry from renowned institutions such as HEC Paris and École normale supérieure de Lyon.